Keywords: Cardiovascular diseases, Market forecasts, GBI Research, Patent losses

Patent losses will drive generics in cardiovascular diseases market to 2018

Article | 27 May 2012

The global generics market cardiovascular drugs is expected to grow rapidly due to the growing dyslipdemia, thrombosis and hypertension populations ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in